Gerrit Bostelmann

Mr. Gerrit Bostelmann

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2023 in Virology Journal
Verified
Journal Article
Open access
PDF file
CLCarlos Loucera
Carlos Loucera
RCROSARIO CARMONA
ROSARIO CARMONA
MEMarina Esteban-Medina
Marina Esteban-Medina
GBGerrit Bostelmann
Gerrit Bostelmann
DMDolores Muñoyerro-Muñiz
Dolores Muñoyerro-Muñiz
JDJoaquin Dopazo
Joaquin Dopazo
Purpose: Despite the extensive vaccination campaigns in many countries, COVID-19 is still a major worldwide health problem because of its associated morbidity and mortality. Therefore, finding efficient treatments as fast as possible is a pressing need. Drug repurposing constitutes a convenient alternative when the need for new drugs in an unexpected medical scenario is urgent, as is the case with COVID-19.Methods: Using data from a central registry of electronic health records (the Andalusian Population Health Database), the effect of prior consumption of drugs for other indications previous to the hospitalization with respect to patient outcomes, including survival and lymphocyte progression, was studied on a retrospective cohort of 15,968 individuals, comprising all COVID-19 patients hospitalized in Andalusia between January and November 2020.Results: Covariate-adjusted hazard ratios and analysis of lymphocyte progression curves support a significant association between consumption of 21 different drugs and better patient survival. Contrarily, one drug, furosemide, displayed a significant increase in patient mortality.Conclusions: In this study we have taken advantage of the availability of a regional clinical database to study the effect of drugs, which patients were taking for other indications, on their survival. The large size of the database allowed us to control covariates effectively.

27 August 2022 in Viruses
Verified
Journal Article
Open access
PDF file
CLCarlos Loucera
Carlos Loucera
JPJavier Perez-Florido
Javier Perez-Florido
CCCarlos S. Casimiro-Soriguer
Carlos S. Casimiro-Soriguer
Francisco OrtuñoFrancisco Ortuño
Francisco Ortuño
RCROSARIO CARMONA
ROSARIO CARMONA
JDJoaquin Dopazo
Joaquin Dopazo
Objectives: More than two years into the COVID-19 pandemic, SARS-CoV-2 still remains a global public health problem. Successive waves of infection have produced new SARS-CoV-2 variants with new mutations for which the impact on COVID-19 severity and patient survival is uncertain. Methods: A total of 764 SARS-CoV-2 genomes, sequenced from COVID-19 patients, hospitalized from 19th February 2020 to 30 April 2021, along with their clinical data, were used for survival analysis. Results: A significant association of B.1.1.7, the alpha lineage, with patient mortality (log hazard ratio (LHR) = 0.51, C.I. = [0.14,0.88]) was found upon adjustment by all the covariates known to affect COVID-19 prognosis. Moreover, survival analysis of mutations in the SARS-CoV-2 genome revealed 27 of them were significantly associated with higher mortality of patients. Most of these mutations were located in the genes coding for the S, ORF8, and N proteins. Conclusions: This study illustrates how a combination of genomic and clinical data can provide solid evidence for the impact of viral lineage on patient survival.

10 July 2022 in medRxiv
Verified
Preprint
Open access
PDF file
CLCarlos Loucera
Carlos Loucera
JPJavier Perez-Florido
Javier Perez-Florido
CCCarlos S. Casimiro-Soriguer
Carlos S. Casimiro-Soriguer
Francisco OrtuñoFrancisco Ortuño
Francisco Ortuño
RCROSARIO CARMONA
ROSARIO CARMONA
JDJoaquin Dopazo
Joaquin Dopazo
After more than two years of COVID-19 pandemic, SARS-CoV-2 still remains a global public health problem. Successive waves of infection have produced new SARS-CoV-2 variants with new mutations whose impact on COVID-19 severity and patient survival is uncertain. A total of 764 SARS-CoV-2 genomes sequenced from COVID-19 patients, hospitalized from 19th February 2020 to 30st April 2021, along with their clinical data, were used for survival analysis. A significant association of B.1.1.7, the alpha lineage, with patient mortality (Log Hazard ratio LHR=0.51, C.I.=[0.14,0.88]) was found upon adjustment by all the covariates known to affect COVID-19 prognosis. Moreover, survival analysis of mutations in the SARS-CoV-2 genome rendered 27 of them significantly associated with higher mortality of patients. Most of these mutations were located in the S, ORF8 and N proteins. This study illustrates how a combination of genomic and clinical data provide solid evidence on the impact of viral lineage on patient survival.

16 August 2022 in medRxiv
Verified
Preprint
Open access
PDF file
CLCarlos Loucera
Carlos Loucera
RCROSARIO CARMONA
ROSARIO CARMONA
MEMarina Esteban-Medina
Marina Esteban-Medina
GBGerrit Bostelmann
Gerrit Bostelmann
DMDolores Muñoyerro-Muñiz
Dolores Muñoyerro-Muñiz
JDJoaquin Dopazo
Joaquin Dopazo
Despite the extensive vaccination campaigns in many countries, COVID-19 is still a major worldwide health problem because of its associated morbidity and mortality. Therefore, finding efficient treatments as fast as possible is a pressing need. Drug repurposing constitutes a convenient alternative when the need for new drugs in an unexpected medical scenario is urgent, as is the case with COVID-19. Using data from a central registry of electronic health records (the Andalusian Population Health Database, BPS), the effect of prior consumption of drugs for other indications previous to the hospitalization with respect to patient survival was studied on a retrospective cohort of 15,968 individuals, comprising all COVID-19 patients hospitalized in Andalusia between January and November 2020. Covariate-adjusted hazard ratios and analysis of lymphocyte progression curves support a significant association between consumption of 21 different drugs and better patient survival. Contrarily, one drug, furosemide, displayed a significant increase in patient mortality.

3 November 2026 in EPJ Data Science
Verified
Journal Article
Open access
PDF file
SKSopho Kharazi
Sopho Kharazi
ASArianna Sala
Arianna Sala
GBGerrit Bostelmann
Gerrit Bostelmann
BKBonka Kotseva
Bonka Kotseva
JLJens P. Linge
Jens P. Linge
EGEmilia Gómez
Emilia Gómez
This study examined global media portrayals of social media bans for minors, focusing on dominant narratives, framing dimensions, and persuasion techniques